MAP2K1 and neoplasm: MEK1/2 inhibition prevents activation of proteins and transcription factors that are dependent on MEK1/2 activation, which can lead to the inhibition of growth factor-mediated cell signaling resulting in inhibition of tumour cell proliferation.